Bleeding risk stratification in acute coronary syndromes. Is it still valid in the era of the radial approach?

Item

http://www.wikidata.org/entity/Q36245021

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Bleeding risk stratification i ...... he era of the radial approach?

@ast

Bleeding risk stratification i ...... he era of the radial approach?

@en

type

Item

label

Bleeding risk stratification i ...... he era of the radial approach?

@ast

Bleeding risk stratification i ...... he era of the radial approach?

@en

prefLabel

Bleeding risk stratification i ...... he era of the radial approach?

@ast

Bleeding risk stratification i ...... he era of the radial approach?

@en

P1476

Bleeding risk stratification i ...... he era of the radial approach?

@en

P2093

Francesco Costa

http://www.w3.org/2001/XMLSchema#string

Giuseppe Andó

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment el

Bivalirudin during primary PCI in acute myocardial infarction

An updated bleeding model to predict the risk of post-procedure bleeding among patients undergoing percutaneous coronary intervention: a report using an expanded bleeding definition from the National Cardiovascular Data Registry CathPCI Registry.

Dual antiplatelet therapy duration after coronary stenting in clinical practice: results of an EAPCI survey.

Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials

Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents

Accuracy of bleeding scores for patients presenting with myocardial infarction: a meta-analysis of 9 studies and 13 759 patients

Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction.

Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score.

Left main or proximal left anterior descending coronary artery disease location identifies high-risk patients deriving potentially greater benefit from prolonged dual antiplatelet therapy duration.

P304

170-173

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5114/PWKI.2015.54007

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Andò

Francesco Costa

P577

2015-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282295362

http://www.w3.org/2001/XMLSchema#string

P698

26677354

http://www.w3.org/2001/XMLSchema#string

P932

4631728

http://www.w3.org/2001/XMLSchema#string